Co-Diagnostics acquires Idaho Molecular and Advanced Conceptions. Co-Diagnostics is working with these companies to develop a PRC test for COVID-19, YourTest. As payment, Co-Diagnostics will issue 4.72 million shares and 456,000 warrants. The transactions are expected to close by the end of 2021.
Co-Diagnostics acquires Idaho Molecular and Advanced Conceptions. Co-Diagnostics is working with these companies to develop a PRC test for COVID-19, YourTest. As payment, Co-Diagnostics will issue 4.72 million shares and 456,000 warrants. The transactions are expected to close by the end of 2021. 
news.codiagnostics.com
English (US) 